Strong cash flow and significant actions to improve profitability within Medtech
Demand is healthy in the markets and segments where AddLife s companies operate. We can now summarize 2023 as a year.
The shareholders of AddLife AB , reg. no 556995-8126, are hereby given notice to attend the Annual General Meeting to be held at 4:00 p.m. CEST, Thursday, 4 May 2023, at World Trade Center, room New. | March 29, 2023